Drug Profile
Research programme: tau protein modulators - BIOALVO
Alternative Names: BLV0703; BLV200703; SDGI-T200801; TAU ProgrammeLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator BIOALVO
- Class
- Mechanism of Action Tau protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes - Neurodegenerative disorders
Highest Development Phases
- No development reported Alzheimer's disease; Neurodegenerative disorders; Parkinson's disease
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Alzheimer's-disease in Portugal
- 16 Jul 2016 No recent reports of development identified for research development in Neurodegenerative-disorders in Portugal
- 16 Jul 2016 No recent reports of development identified for research development in Parkinson's-disease in Portugal